Clinical Recommendations for the Use of Donepezil 23 mg in Moderate-to-Severe Alzheimer's Disease in the Asia-Pacific Region
Background: The ‘Asia-Pacific Expert Panel (APEX) for donepezil 23 mg' met in November 2015 to review evidence for the recently approved high dose of donepezil and to provide recommendations to help physicians in Asia make informed clinical decisions about using donepezil 23 mg in patients with...
Main Authors: | Marwan Sabbagh, SeolHeui Han, SangYun Kim, Hae-Ri Na, Jae-Hong Lee, Nagaendran Kandiah, Kammant Phanthumchinda, Chuthamanee Suthisisang, Vorapun Senanarong, Ming-Chyi Pai, Diatri Narilastri, Ajit M. Sowani, Encarnita Ampil, Amitabh Dash |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2016-09-01
|
Series: | Dementia and Geriatric Cognitive Disorders Extra |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/448214 |
Similar Items
-
Clinical Assessment of Alzheimer’s Disease and Response to Donepezil Treatment
by: Serge Gauthier
Published: (2020-12-01) -
Suspected donepezil toxicity: A case report
by: Carmen Gust, et al.
Published: (2020-12-01) -
Long-term safety and tolerability of donepezil 23 mg in patients with moderate to severe Alzheimer’s disease
by: Tariot Pierre, et al.
Published: (2012-06-01) -
Delirium associated with donepezil in a patient with Alzheimer's disease: a case report.
by: Kamyar Mollazadeh-Moghaddam, et al.
Published: (2013-03-01) -
Delirium Associated with Donepezil in a Patient with Alzheimer’s Disease: a Case Report
by: Kamyar Mollazadeh-Moghaddam, et al.
Published: (2013-03-01)